These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10816622)

  • 1. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma.
    Li W; Stall A; Shivers SC; Lin J; Haddad F; Messina J; Glass LF; Lyman G; Reintgen DS
    Ann Surg; 2000 Jun; 231(6):795-803. PubMed ID: 10816622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of molecular staging for melanoma.
    Shivers SC; Li W; Lin J; Stall A; Stafford M; Messina J; Glass LF; Reintgen DS
    Recent Results Cancer Res; 2001; 158():187-99. PubMed ID: 11092046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
    Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
    Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular staging of malignant melanoma: correlation with clinical outcome.
    Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
    JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
    Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
    Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
    Kammula US; Ghossein R; Bhattacharya S; Coit DG
    J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the RT-PCR positive sentinel node in melanoma.
    Temple CL; Snell LJ; Power SM; Parfitt JR; Scilley C; Engel CJ; Shum D; Chakrabarti S; Joseph MG; Lohmann RC; Ainsworth P
    J Surg Oncol; 2007 Jun; 95(7):546-54. PubMed ID: 17219388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
    Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
    Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.
    Denninghoff VC; Kahn AG; Falco J; Curutchet HP; Elsner B
    Mol Diagn; 2004; 8(4):253-8. PubMed ID: 15887981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients.
    Blaheta HJ; Roeger S; Sotlar K; Schittek B; Breuninger H; Bueltmann B; Garbe C
    Br J Dermatol; 2004 Mar; 150(3):477-83. PubMed ID: 15030330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
    J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
    Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
    Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
    Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C
    Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
    Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
    J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma.
    Ribuffo D; Gradilone A; Vonella M; Chiummariello S; Cigna E; Haliassos N; Massa R; Silvestri I; Calvieri S; Frati L; Aglianò AM; Scuderi N
    Ann Surg Oncol; 2003 May; 10(4):396-402. PubMed ID: 12734088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
    Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
    Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR.
    van der Velde-Zimmermann D; Schipper ME; de Weger RA; Hennipman A; Borel Rinkes IH
    Ann Surg Oncol; 2000; 7(1):51-4. PubMed ID: 10674449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.
    Romanini A; Manca G; Pellegrino D; Murr R; Sarti S; Bianchi F; Alsharif A; Orlandini C; Zucchi V; Castagna M; Gandini D; Salimbeni G; Ghiara F; Barachini P; Mariani G
    Ann Oncol; 2005 Nov; 16(11):1832-40. PubMed ID: 16107497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.